pI: 5.0671 |
Length (AA): 724 |
MW (Da): 88458 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
37 | 165 | 2fo7 (A) | 1 | 129 | 14.00 | 0 | 0.33 | 0.5 | -1.6 |
69 | 152 | 1na3 (A) | 2 | 85 | 15.00 | 0.0000000000031 | 0.77 | 0.57 | -2.38 |
103 | 610 | 2gw1 (A) | 97 | 606 | 12.00 | 0 | 0.99 | 0.79 | 0.11 |
2 | 115 | 1a17 (A) | 27 | 140 | 16.00 | 0.00026 | 0.1 | 0.379559 | -0.75 |
2 | 98 | 3vtx (A) | 77 | 173 | 14.00 | 0.03 | 0.05 | 0.373078 | -1.17 |
7 | 63 | 2fxm (B) | 890 | 946 | 30.00 | 0.57 | 0.01 | 0.475529 | -1.05 |
95 | 539 | 2ooe (A) | 22 | 471 | 24.00 | 0.00000000019 | 1 | 0.671441 | 0.64 |
269 | 407 | 3bma (A) | 241 | 359 | 38.00 | 0.45 | 0.67 | 0.170789 | 1.99 |
316 | 460 | 4h7y (A) | 12 | 142 | 27.00 | 0.11 | 1 | 0.489076 | -0.48 |
560 | 716 | 4uos (A) | 25 | 183 | 18.00 | 0.25 | 0.23 | 0.356151 | -0.57 |
685 | 717 | 4is1 (C) | 473 | 505 | 6.00 | 0.45 | 0 | 0.30968 | -2.27 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_128090)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G41770 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT3G13210 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT5G45990 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT3G51110 | Half-A-TPR repeat-containing protein |
Babesia bovis | BBOV_III004750 | tetratricopeptide repeat domain containing protein |
Brugia malayi | Bm1_50550 | Crooked neck-like protein 1 |
Candida albicans | CaO19.7964 | similar to factor involved in both pre-mRNA splicing and cell cycle progression |
Candida albicans | CaO19.332 | similar to factor involved in both pre-mRNA splicing and cell cycle progression |
Caenorhabditis elegans | CELE_M03F8.3 | Protein M03F8.3, isoform B |
Cryptosporidium hominis | Chro.70412 | hypothetical protein |
Cryptosporidium parvum | cgd7_3690 | crooked neck protein HAT repeats |
Dictyostelium discoideum | DDB_G0278819 | HAT repeat-containing protein |
Drosophila melanogaster | Dmel_CG3193 | crooked neck |
Echinococcus granulosus | EgrG_000844800 | crooked neck pre mRNA splicing factor 1 |
Entamoeba histolytica | EHI_175230 | crooked neck protein, putative |
Echinococcus multilocularis | EmuJ_000844800 | crooked neck pre mRNA splicing factor 1 |
Homo sapiens | ENSG00000101343 | crooked neck pre-mRNA splicing factor 1 |
Leishmania braziliensis | LbrM.35.4530 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_364490.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.36.4490 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4280 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4280 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03190 | crooked neck |
Mus musculus | ENSMUSG00000001767 | Crn, crooked neck-like 1 (Drosophila) |
Neospora caninum | NCLIV_037180 | hypothetical protein |
Oryza sativa | 4338298 | Os05g0289400 |
Oryza sativa | 4348330 | Os10g0328700 |
Oryza sativa | 9268891 | Os06g0523800 |
Plasmodium berghei | PBANKA_1001400 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium falciparum | PF3D7_0403700 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium knowlesi | PKNH_0301700 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium vivax | PVX_001060 | splicing factor, putative |
Plasmodium yoelii | PY02447 | hypothetical protein |
Saccharomyces cerevisiae | YLR117C | Clf1p |
Schistosoma japonicum | Sjp_0048020 | Crooked neck-like protein 1, putative |
Schistosoma mansoni | Smp_148230 | Pre-mRNA-splicing factor CLF1 |
Schmidtea mediterranea | mk4.007501.00 | Crooked neck-like protein 1 |
Schmidtea mediterranea | mk4.001551.03 | Crooked neck-like protein 1 |
Trypanosoma brucei gambiense | Tbg972.10.11820 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0735 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.9660 | Splicing factor CRN, putative |
Trypanosoma congolense | TcIL3000_10_8690 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma cruzi | TcCLB.504147.320 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_269200 | crooked neck family 1 protein isoform 2, putative |
Theileria parva | TP02_0476 | crooked neck protein, putative |
Trichomonas vaginalis | TVAG_139790 | crooked neck protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9660 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9660 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9660 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.9660 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_M03F8.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_M03F8.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_M03F8.3 | Caenorhabditis elegans | sterile | wormbase |
YLR117C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1001400 | Plasmodium berghei | Essential | plasmo |
TGME49_269200 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.